CERONI, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 11.067
AS - Asia 7.691
EU - Europa 6.767
SA - Sud America 820
AF - Africa 191
Continente sconosciuto - Info sul continente non disponibili 154
OC - Oceania 22
Totale 26.712
Nazione #
US - Stati Uniti d'America 10.810
CN - Cina 3.971
SG - Singapore 1.704
IE - Irlanda 1.429
UA - Ucraina 1.080
DE - Germania 819
FI - Finlandia 793
HK - Hong Kong 760
RU - Federazione Russa 612
BR - Brasile 596
VN - Vietnam 590
SE - Svezia 578
IT - Italia 426
FR - Francia 403
GB - Regno Unito 375
IN - India 160
CA - Canada 133
ZA - Sudafrica 91
AR - Argentina 74
BD - Bangladesh 72
IQ - Iraq 58
JP - Giappone 58
MX - Messico 58
PK - Pakistan 45
CO - Colombia 35
VE - Venezuela 35
PL - Polonia 34
NL - Olanda 33
TR - Turchia 33
ES - Italia 31
BE - Belgio 30
EC - Ecuador 29
ID - Indonesia 29
AT - Austria 22
CL - Cile 20
MA - Marocco 20
PH - Filippine 20
UZ - Uzbekistan 19
AU - Australia 18
EG - Egitto 17
KE - Kenya 17
MY - Malesia 16
SA - Arabia Saudita 16
CZ - Repubblica Ceca 15
AE - Emirati Arabi Uniti 13
JO - Giordania 13
LT - Lituania 12
PY - Paraguay 12
AZ - Azerbaigian 11
IL - Israele 11
JM - Giamaica 11
TN - Tunisia 11
PT - Portogallo 10
DO - Repubblica Dominicana 9
DZ - Algeria 9
IR - Iran 9
KG - Kirghizistan 8
NP - Nepal 8
AL - Albania 7
LV - Lettonia 7
OM - Oman 7
PA - Panama 7
BG - Bulgaria 6
CH - Svizzera 6
ET - Etiopia 6
HN - Honduras 6
KZ - Kazakistan 6
LB - Libano 6
NI - Nicaragua 6
PE - Perù 6
BO - Bolivia 5
BY - Bielorussia 5
GR - Grecia 5
KR - Corea 5
PR - Porto Rico 5
SY - Repubblica araba siriana 5
TH - Thailandia 5
TW - Taiwan 5
UY - Uruguay 5
CR - Costa Rica 4
GE - Georgia 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
RO - Romania 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
CG - Congo 3
EU - Europa 3
GT - Guatemala 3
KW - Kuwait 3
LU - Lussemburgo 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
Totale 26.519
Città #
Chandler 1.477
Dublin 1.423
Jacksonville 1.228
San Jose 1.009
Nanjing 935
Ashburn 873
Singapore 863
Hong Kong 743
Dallas 682
Beijing 511
Boardman 495
Council Bluffs 429
Nanchang 358
Princeton 285
Lawrence 276
Shenyang 268
Hebei 264
Wilmington 260
Lauterbourg 248
Changsha 240
Helsinki 237
Jiaxing 233
Los Angeles 229
Ho Chi Minh City 203
Medford 193
Ann Arbor 184
Munich 164
New York 160
Buffalo 159
Hangzhou 156
Tianjin 149
Hanoi 145
Moscow 129
Shanghai 103
Santa Clara 101
Milan 96
Woodbridge 95
Johannesburg 70
Redondo Beach 68
São Paulo 66
Pavia 60
Turku 58
Verona 56
Norwalk 53
Tokyo 53
Falkenstein 50
Dearborn 49
Toronto 48
Orem 46
Houston 44
Seattle 41
Da Nang 39
Montreal 34
Chicago 33
San Francisco 33
Frankfurt am Main 31
Haiphong 31
Rome 31
Zhengzhou 31
Brussels 29
Chennai 29
Brooklyn 28
Fairfield 28
Kunming 28
Stockholm 28
Warsaw 27
Atlanta 26
Boston 26
The Dalles 26
Des Moines 25
London 24
Nuremberg 24
Jinan 23
Guangzhou 22
Pune 21
Denver 20
Manchester 20
Rio de Janeiro 19
Falls Church 18
Tashkent 18
Auburn Hills 17
Phoenix 17
Poplar 17
Dhaka 16
Washington 16
Caracas 15
Mexico City 15
Baghdad 14
Lahore 14
Mumbai 14
Ningbo 14
Nairobi 13
Buenos Aires 12
Changchun 12
Hải Dương 12
Ottawa 12
Quito 12
Vienna 12
Belo Horizonte 11
Curitiba 11
Totale 17.413
Nome #
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment 163
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis 161
2-DE AND MALDI-TOF-MS FOR A COMPARATIVE ANALYSIS OF PROTEINS EXPRESSED IN DIFFERENT CELLULAR MODELS OF AMYOTROPHIC LATERAL SCLEROSIS 157
Acute disseminated encephalomyelitis: Clinical, biological, neurophysiological and radiological prognostic markers 146
Activated lymphocytes in glioblastoma: significance for anti-tumoral immunity 145
Meningeal melanomatosis: a challenge for timely diagnosis. 145
SOD1 activity and protective factors in familial ALS patients with L84F SOD1 mutation 145
A Randomized Phase III study: Comparison between Intra-venous and Intra-arterial ACNU Administration in Newly Diagnosed Primary Glioblastomas. 143
Clustering of ALS patients in central Italy due to the occurrence of the L84F SOD1 gene mutation 141
ISOLATION OF GENETIC MARKERS FROM HUMAN GLIOBLASTOMA CELLS BY DIFFERENTIAL DISPLAY TECHNIQUE 139
Immunocytochemical detection of the Interleukin-2 receptors a and b on cell surface of normal and pathological cells. 139
Analysis immunohistochemical of the HLA class I molecules in human glioma. 139
Autofluorescence-assisted delineation of glioblastoma resection margins. 138
Lower motor neuron disease with respiratory failure caused by a novel MAPT mutation. 138
Differential expression of the prion-like protein doppel gene (PRND) in astrocytomas: a new molecular marker potentially involved in tumor progression. 138
Analysis of HLA antigen expression in formalin-fixed, paraffin-embedded astrocytic tumours. 137
Activated lymphoid cells in human gliomas: morphofunctional and cytochemical evidence. 135
A prospective cohort study in JCV and non JCV-related leukoencephalopathies in HIV patients 135
Balance between proliferation and cell death in 8 selected supratentorial pilocytic astrocytomas. 132
Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes 132
Molecular and cellular insights into the aberrant expression of the prion protein-like gene doppel in astrocytic tumors 132
Predictors of outcome in a large retrospective cohort of patients with transverse myelitis 132
Acute Disseminated Encephalomyelitis (ADEM): A Prospective Study on 122 Adults 131
COVID-19 and Guillain–Barré Syndrome: A Case Report and Review of Literature 131
Detection of a novel antineuronal antibody in paraneoplastic brainstem encephalitis. 130
Antibodies to cerebellar nerve fibres in two patients with paraneoplastic cerebellar ataxia. 130
Trauma and amyotrophic lateral sclerosis: A case-control study from a population-based registry 130
Cytochemical demonstration of nitric oxide synthase and 5' nucleotidase in human glioblastoma 127
Activated lymphoid cells in human gliomas: morphofunctional and cytochemical evidence 127
Ectopic expression of the prion-like protein doppel in human astrocytoma cells 127
Acute late-onset encephalopathy after radiotherapy: an unusual life-threatening complication 126
The prion protein-like gene Doppel is aberrantly expressed in astrocytic tumors 126
Late post-transplant anti-aquaporin-4 Ab-positive optic neuritis in a patient with AML 126
Diagnostic potential of autofluorescence for an assisted intraoperative delineation of glioblastoma resection margins 124
Immunohistochemical and in situ hybridization localization of doppel protein as a new marker astrocytic tumour progression. 124
Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients 123
SOD1 activity and protective factors in familial ALS patients with L84F SOD1 mutation 123
Mini Nutritional Assessment May Identify a Dual Pattern of Perturbed Plasma Amino Acids in Patients with Alzheimer's Disease: A Window to Metabolic and Physical Rehabilitation? 123
Early cortical and late striatal diffusion restriction on 3T MRI in long-lived sporadic Creutzfeldt-Jakob disease case. 122
Analysis of HLA class I antigen and antigen-processing machinery components in human brain tumours. 122
Postinfectious neurologic syndromes: A prospective cohort study 121
A novel compound heterozygous mutation of C20orf54 gene associated with Brown-Vialetto-Van Laere syndrome in an Italian family 121
Abbiategrasso brain bank protocol for collecting, processing and characterizing aging brains 121
Cytochemical demonstration of nitric oxide synthase and 5' nucleotidase in human glioblastoma. 120
Severe recurrent myelitis in patients with hepatitis C virus infection 120
About the original description of cerebellar tonsil herniation by Pierre Marie. 120
Basic and clinical research on amyotrophic lateral sclerosis and other motor neuron disorders in Italy: recent findings and achievements from a network of laboratories 119
Autofluorescence-based real time diagnosis for selective resection of tumors in neurosurgery. 119
Lateral gaze synkinesis on downward saccade attempts with paramedian thalamic and midbrain infarct 118
Posttranscriptional regulation of SOD1 gene expression under oxidative stress: Potential role of ELAV proteins in sporadic ALS 118
Thiamin mono- and pyrophosphatase activities from brain homogenate of Guamanian amyotrophic lateral sclerosis and parkinsonism-dementia patients. 118
Leukocite derived microvescicles as disease progression biomarkers in slow progressing amyotrophic lateral sclerosis. 118
Immunohistochemical expression of HLA antigens and components of the antigen processing machinery in astrocytic tumors. 117
Experimental diets for the prevention of the development of familial amyotrophic lateral sclerosis 117
Activity of protein phosphatase calcineurin in decreased in sporadic and familiar amyotrophic lateral sclerosis patients. 117
NMO-IgG-negative relapsing myelitis 116
Long non-coding and coding RNAs characterization in Peripheral Blood Mononuclear Cells and Spinal Cord from Amyotrophic Lateral Sclerosis patients 116
Extracellular Vesicles Derived From Plasma of Patients With Neurodegenerative Disease Have Common Transcriptomic Profiling 116
Comparison of different immunohistochemical techniques for detection of anti-neuronal specific antibodies. 115
Cerebrospinal fluid ferritin in human disease. 115
Altered intracellular localization of SOD1 in leukocytes from patients with sporadic amyotrophic lateral sclerosis 115
HIV-RELATED ACUTE INFLAMMATORY LEUKOENCEPHALOPATHY OF UNDETERMINED ORIGIN: SYSTEMATIC REVIEW OF THE LITERATURE 115
Detection of SARS-CoV-2 genome and whole transcriptome sequencing in frontal cortex of COVID-19 patients 114
Experimental diets for the prevention of the development of familial amyotrophic lateral sclerosis 114
Detection of HTLV-III specific IgG in the CSF from patient with AIDS and encephalitis. 114
Heterogeneous distribution of amyotrophic lateral sclerosis patient with SOD-1 gene mulations: preliminary data on an Italian survey 113
Immunohistochemical analysis to estimate actively proliferating, competent to proliferate and differentiated cell subsets in astrocytic tumours. 113
Doppel protein as a new marker in astrocytic tumour progression 112
Changes in skeletal muscle qualities during enzyme replacement therapy in late-onset type II glycogenosis: temporal and spatial pattern of mass vs. strength response. 111
Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encphalomyelitis. 111
Different miRNA profiles in plasma derived small and large extracellular vesicles of neurodegenerative disease patients. 111
COVID-19 Pathology in the Lung, Kidney, Heart and Brain: The Different Roles of T-Cells, Macrophages, and Microthrombosis 110
Immunohistochemistry and in situ hybridization of “Doppel protein” in human astrocytic tumours 110
Study of HLA class I antigen and antigen-processing machinery components in human glioblastoma. 109
Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan 109
Frontal and cerebellar atrophy supports FTSD-ALS clinical continuum 109
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis 108
Systemic sclerosis in aquaporin-4 antibody-positive longitudinally extensive transverse myelitis 108
Myelin basic protein purification in non denaturing conditions. 107
Amyotrophic lateral sclerosis and SOD1 gene: an overview 106
Interleukin-2 induces the growth of human glioblastoma cells in culture. 105
Severe recurrent myelitis in patients with hepatitis C virus infection patients 105
Clinical and MRI logitudinal study in two case-reports of long-lasting sCJD patients 105
Combined central and peripheral demyelination: comparison of adult and pediatric series 104
Molecular mass, biochemical composition, and physicochemical behavior of the infectious form of the scrapie precursor protein monomer. 104
RNA-seq profiling in peripheral blood mononuclear cells of amyotrophic lateral sclerosis patients and controls 103
Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease. 102
Purification of non-infectious ganglioside preparations from scrapie-infected brain tissue. 102
THE DDRT ANALYSIS AS A MOLECULAR TOOL TO IDENTIFY EXPRESSION DIFFERENCES AMONG GLIAL TUMORS 102
Optimizing separation efficiency of 2-DE procedures for visualization of different superoxide dismutase forms in a cellular model of amyotrophic lateral sclerosis 102
Anomalie del deflusso venoso cerebrale in pazienti affetti da Sclerosi Multipla: valutazione con Doppler venoso e correlazioni cliniche 102
Disseminated encephalitis following streptococcal infection. 101
Late-onset myopathy after radiation therapy for thymoma in a young patient with myastenia gravis 101
Doppel protein as a new marker in astrocytic tumour progression. 101
Human Leukocyte Antigen and antigen processing machinery component defects in astrocytic tumors. 101
Dejerine's syndrome or Spille's syndrome? 100
Gene-environment interaction in parkinson's disease. The case of CYP2D6 polymorphism. 100
SELDI-TOF/MS detection of SOD1 enzyme expression levels: potential usefulness in the differential diagnosis of Amyotrophic Lateral Sclerosis 100
Nuclear Phospho-SOD1 Protects DNA from Oxidative Stress Damage in Amyotrophic Lateral Sclerosis 100
DIFFERENTIAL EXPRESSION OF THE PRION GENE FAMILY IN GLIOBLASTOMA TUMORS. 99
Totale 12.004
Categoria #
all - tutte 110.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.933


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.095 0 0 28 13 12 28 31 51 65 14 203 650
2022/20234.121 467 289 61 313 474 443 2 201 1.673 34 109 55
2023/20241.427 166 253 33 134 152 350 53 113 8 44 34 87
2024/20253.437 70 324 101 139 74 127 127 268 806 79 339 983
2025/20268.057 629 669 889 793 914 423 1.578 265 742 609 338 208
2026/2027623 149 438 36 0 0 0 0 0 0 0 0 0
Totale 26.712